Suppr超能文献

过氧化物酶体增殖物激活受体-γ 可预防血管老化。

Peroxisome proliferator-activated receptor-γ protects against vascular aging.

机构信息

Department of Internal Medicine, Cardiovascular Center, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242-1081, USA.

出版信息

Am J Physiol Regul Integr Comp Physiol. 2012 May 15;302(10):R1184-90. doi: 10.1152/ajpregu.00557.2011. Epub 2012 Mar 28.

Abstract

Vascular disease occurs commonly during aging. Carotid artery and cerebrovascular disease are major causes of stroke and contributors to dementia. Recent evidence suggests that peroxisome proliferator-activated receptor-γ (PPARγ) may play a protective role in the vasculature, but the potential importance of PPARγ in vascular aging is unknown. To examine the hypothesis that PPARγ normally protects against vascular aging, we studied heterozygous knockin mice expressing a human dominant-negative mutation in PPARγ (P465L, designated L/+). Endothelial dysfunction, a major contributor to vascular disease, was studied using carotid arteries from adult (8 ± 1 mo) and old (24 ± 1 mo) L/+ mice and wild-type littermates. In arteries from wild-type mice, responses to the endothelium-dependent agonist ACh were similar in adult and old wild-type mice but were reduced by ∼50% in old L/+ mice (n = 7-10, P < 0.05). Impaired responses in arteries from old L/+ mice were restored to normal by a scavenger of superoxide. Relaxation of arteries to nitroprusside (an NO donor) was similar in all groups. Contraction of arteries to U46619 was not affected by age or genotype, while maximal responses to endothelin-1 were reduced with age in both wild-type and L/+ mice. Vascular expression (mRNA) of the catalytic component of NADPH oxidase (Nox2) was not altered in wild-type mice but was increased significantly in old L/+ mice. These findings provide the first evidence that interference with PPARγ function accelerates vascular aging, suggesting a novel role for PPARγ in protecting against age-induced oxidative stress and endothelial dysfunction.

摘要

血管疾病在衰老过程中很常见。颈动脉和脑血管疾病是中风的主要原因,也是痴呆的促成因素。最近的证据表明,过氧化物酶体增殖物激活受体-γ(PPARγ)在血管中可能发挥保护作用,但 PPARγ 在血管老化中的潜在重要性尚不清楚。为了检验 PPARγ 正常情况下可防止血管老化的假说,我们研究了表达人源显性负突变 PPARγ(P465L,命名为 L/+)的杂合敲入小鼠。使用来自成年(8±1 个月)和老年(24±1 个月)L/+ 小鼠和野生型同窝小鼠的颈动脉研究内皮功能障碍,内皮功能障碍是血管疾病的主要原因之一。在野生型小鼠的动脉中,对内皮依赖性激动剂 ACh 的反应在成年和老年野生型小鼠中相似,但在老年 L/+ 小鼠中降低了约 50%(n=7-10,P<0.05)。老年 L/+ 小鼠动脉中受损的反应通过超氧化物清除剂恢复正常。所有组的血管对硝普钠(NO 供体)的松弛反应相似。血管对 U46619 的收缩不受年龄或基因型影响,而内皮素-1的最大反应在野生型和 L/+ 小鼠中均随年龄而降低。NADPH 氧化酶(Nox2)的催化成分在野生型小鼠中的血管表达(mRNA)没有改变,但在老年 L/+ 小鼠中显著增加。这些发现首次提供了证据表明,干扰 PPARγ 功能会加速血管老化,表明 PPARγ 在防止年龄引起的氧化应激和内皮功能障碍方面具有新的作用。

相似文献

1
Peroxisome proliferator-activated receptor-γ protects against vascular aging.
Am J Physiol Regul Integr Comp Physiol. 2012 May 15;302(10):R1184-90. doi: 10.1152/ajpregu.00557.2011. Epub 2012 Mar 28.
2
Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.
Hypertension. 2018 Jul;72(1):227-234. doi: 10.1161/HYPERTENSIONAHA.117.10799. Epub 2018 May 7.
4
Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress.
Am J Physiol Heart Circ Physiol. 2016 Jan 1;310(1):H39-48. doi: 10.1152/ajpheart.00490.2015. Epub 2015 Nov 13.
6
Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.
Hypertension. 2008 Apr;51(4):867-71. doi: 10.1161/HYPERTENSIONAHA.107.103648. Epub 2008 Feb 19.
7
Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction.
Physiol Genomics. 2016 Feb;48(2):124-34. doi: 10.1152/physiolgenomics.00087.2015. Epub 2015 Nov 3.
9
Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene.
Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1001-10. doi: 10.1152/ajpheart.00761.2013. Epub 2014 Jan 31.
10
Curcumin ameliorates arterial dysfunction and oxidative stress with aging.
Exp Gerontol. 2013 Feb;48(2):269-76. doi: 10.1016/j.exger.2012.10.008. Epub 2012 Nov 7.

引用本文的文献

1
Relationship between PPAR-γ gene polymorphisms and ischemic stroke risk: A meta-analysis.
Brain Behav. 2021 Dec;11(12):e2434. doi: 10.1002/brb3.2434. Epub 2021 Nov 10.
2
PPAR Targeting GDF11 Inhibits Vascular Endothelial Cell Senescence in an Atherosclerosis Model.
Oxid Med Cell Longev. 2021 Feb 25;2021:2045259. doi: 10.1155/2021/2045259. eCollection 2021.
3
Effects and Mechanisms of Five Psoralea Prenylflavonoids on Aging-Related Diseases.
Oxid Med Cell Longev. 2020 Jun 17;2020:2128513. doi: 10.1155/2020/2128513. eCollection 2020.
4
PPARγ and RhoBTB1 in hypertension.
Curr Opin Nephrol Hypertens. 2020 Mar;29(2):161-170. doi: 10.1097/MNH.0000000000000579.
5
Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.
Neurotox Res. 2019 Oct;36(3):583-601. doi: 10.1007/s12640-019-00047-5. Epub 2019 May 4.
6
Restoring mitochondrial DNA copy number preserves mitochondrial function and delays vascular aging in mice.
Aging Cell. 2018 Aug;17(4):e12773. doi: 10.1111/acel.12773. Epub 2018 May 9.
7
Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.
Hypertension. 2018 Jul;72(1):227-234. doi: 10.1161/HYPERTENSIONAHA.117.10799. Epub 2018 May 7.
9
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Front Pharmacol. 2016 Mar 17;7:61. doi: 10.3389/fphar.2016.00061. eCollection 2016.
10
The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia.
Oxid Med Cell Longev. 2015;2015:504678. doi: 10.1155/2015/504678. Epub 2015 Aug 2.

本文引用的文献

1
Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption.
Hypertension. 2012 Apr;59(4):818-24. doi: 10.1161/HYPERTENSIONAHA.111.189456. Epub 2012 Feb 21.
2
Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.
Aging Cell. 2012 Apr;11(2):269-76. doi: 10.1111/j.1474-9726.2011.00783.x. Epub 2012 Jan 19.
4
Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly.
Circulation. 2011 May 3;123(17):1900-10. doi: 10.1161/CIRCULATIONAHA.110.009118.
5
Protecting against vascular disease in brain.
Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1566-82. doi: 10.1152/ajpheart.01310.2010. Epub 2011 Feb 18.
6
Aging and vascular endothelial function in humans.
Clin Sci (Lond). 2011 May;120(9):357-75. doi: 10.1042/CS20100476.
7
Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia.
J Appl Physiol (1985). 2011 Feb;110(2):329-39. doi: 10.1152/japplphysiol.01159.2010. Epub 2010 Nov 11.
8
The nuclear hormone receptor PPARγ as a therapeutic target in major diseases.
ScientificWorldJournal. 2010 Nov 4;10:2181-97. doi: 10.1100/tsw.2010.213.
9
Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging.
Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1933-9. doi: 10.1161/ATVBAHA.110.206342. Epub 2010 Aug 5.
10
PPARs in the Renal Regulation of Systemic Blood Pressure.
PPAR Res. 2010;2010:698730. doi: 10.1155/2010/698730. Epub 2010 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验